用英文对以下摘要提几个问题:AbstractAims Radiofrequency ablation RFA is clinically adopted to destroy hepatocellular carcinoma but is often incapable of completely ablating large tumors and those with multiple meta
- What is the aim of this study?
- What are the limitations of radiofrequency ablation (RFA) in treating hepatocellular carcinoma?
- What is the role of vascular embolization in enhancing local therapeutic efficacy?
- Why do most patients not benefit from the combination of RFA and vascular embolization?
- How does anaerobic glycolysis relate to immunosuppression?
- What is the proposed solution to induce robust antitumor immune responses?
- What is the magnetic vascular embolic agent and how is it constructed?
- How does the Thrombin-ZnTA-Fe3O4-PFP embolic agent enhance the efficacy of RFA?
- What is the mechanism by which Zn2+ inhibits lactic acid production?
- How does the combination of Thrombin-ZnTA-Fe3O4-PFP with anti-programmed cell death protein-1 antibody (aPD-1) enhance antitumor response
原文地址: https://www.cveoy.top/t/topic/gAXb 著作权归作者所有。请勿转载和采集!